ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,413, issued on April 29.
"Anti-viral agents and methods for administration thereof" was invented by John M.H. Gregg (Princeton, N.J.).
According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to the use of anti-viral drugs with different mechanisms of action for the treating or preventing of viral infections such as COVID-19 (also known as SARS-CoV-2) and reducing medical complications related to COVID-19 viral disease. The present invention also relates to compositions and combinations of new antiviral drugs, and the administration of these compounds used in these various new combinations, that are incorporated into oral, pulmonary, or in...